Regulation of Osteopontin Gene Expression in Osteoblasts a
1995; Wiley; Volume: 760; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1995.tb44634.x
ISSN1749-6632
AutoresMasaki Noda, David T. Denhardt,
Tópico(s)TGF-β signaling in diseases
ResumoAnnals of the New York Academy of SciencesVolume 760, Issue 1 p. 242-248 Regulation of Osteopontin Gene Expression in Osteoblastsa MASAKI NODA, Corresponding Author MASAKI NODA Department of Molecular Pharmacology Division of Functional Disorder Research Medical Research Institute Tokyo Medical and Dental University 3–10, Kanda-Surugadai 2-Chrome, Chiyoda-Ku Tokyo 101, JapanCorresponding author.Search for more papers by this authorDAVID T. DENHARDT, DAVID T. DENHARDT Department of Biological Sciences Nelson Biological Laboratories Rutgers University P.O. Box 1059 Piscataway, New Jersey 08855–1059Search for more papers by this author MASAKI NODA, Corresponding Author MASAKI NODA Department of Molecular Pharmacology Division of Functional Disorder Research Medical Research Institute Tokyo Medical and Dental University 3–10, Kanda-Surugadai 2-Chrome, Chiyoda-Ku Tokyo 101, JapanCorresponding author.Search for more papers by this authorDAVID T. DENHARDT, DAVID T. DENHARDT Department of Biological Sciences Nelson Biological Laboratories Rutgers University P.O. Box 1059 Piscataway, New Jersey 08855–1059Search for more papers by this author First published: August 1995 https://doi.org/10.1111/j.1749-6632.1995.tb44634.xCitations: 14 a Abbreviations: BMP, bone morphogenetic protein; OPN, osteopontin; PTH, parathyroid hormone; TGF, transforming growth factor. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Butler, W. T. 1989. The nature and significance of osteopontin. Connect. Tissue Res. 23: 123–136. 2 Sodek, J., J. Chen, S. Kasugai, T. Nagata, Q. Zhang, M. D. McKee & A. Nanci. 1992. Elucidating the functions of bone sialoprotein and osteopontin in bone formation. In Chemistry and Biology of Mineralized Tissues. H. Slavkin & P. Price, Eds. 297–306. Elsevier Science Publishers B.V. Amsterdam . 3 Ten Dijke, P., H. Yamashita, T. K. Sampath, A. H. Reddi, M. Estevez, D. L. Riddle, H. Ichijo, C.-H. Heldin & K. Miyazono. 1994. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985–16988. 4 Noda, M., K. Yoon, C. W. Prince, W. T. Butler & G. A. Rodan. 1988. Transcriptional regulation of osteopontin production in rat osteosarcoma cells by TGFβ transforming growth factor. J. Biol. Chem. 263: 13916–13921. 5 Fukayama, S., E. Schipani, H. Juppner, B. Lanski, H. M. Kronenberg, A. B. Abou-Samra & F. R. Bringhurst. 1994. Role of protein kinase A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor mRNA in human osteoblast-like SaOS-2 cells. Endocrinology 134: 1851–1858. 6 Noda, M. & G. A. Rodan. 1989. Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone. J. Cell Biol. 108: 713–718. 7 Noda, M., R. L. Vogel, A. M. Craig, J. Prahl, H. F. Deluca & D. T. Denhardt. 1990. Identification of a DNA sequence responsible for binding of the 1,25-dihydroxy-vitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc. Natl. Acad. Sci. USA 87: 9995–9999. 8 Shioide, M. & M. Noda. 1993. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. J. Cell. Biochem. 53: 176–180. 9 Tsukahara, H., H. Ende, H. I. Magazine, W. F. Bahou & M. S. Goligorsky. 1994. Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. J. Biol. Chem. 269: 21778–21785. 10 Hwang, S.-M., C. A. Lopez, D. E. Heck, C. R. Gardner, D. L. Laskin, J. D. Laskin & D. T. Denhardt. 1994. Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. J. Biol. Chem. 269: 711–715. 11 Sampath, T. K., J. C. Maliakal, P. V. Hauschka, W. K. Jones, H. Sasak, R. F. Tucker, K. H. White, J. E. Coughlin, M. M. Tucker, R. H. L. Pang, C. Corbett, E. Ozkaynak, H. Oppermann & D. C. Rueger. 1992. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo and with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267: 20352–20362. 12 Kingsley, D. M. 1994. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133–146. 13 Ogata, T. & M. Noda. 1991. Expression of Id, a member of the HLH protein family, is down-regulated at confluence and enhanced by dexamethasone in a mouse osteoblastic cell line, MC3T3E1. Biochem. Biophys. Res. Commun. 180: 1194–1199. 14 Tamura, M. & M. Noda. 1994. Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors. J. Cell Biol. 126: 773–782. Citing Literature Volume760, Issue1Osteopontin: Role in Cell Signalling and AdhesionAugust 1995Pages 242-248 ReferencesRelatedInformation
Referência(s)